Mechanisms and clinical uses of capsaicin
- PMID: 24211679
- DOI: 10.1016/j.ejphar.2013.10.053
Mechanisms and clinical uses of capsaicin
Abstract
Capsaicin is the active ingredient of chili peppers and gives them the characteristic pungent flavor. Understanding the actions of capsaicin led to the discovery of its receptor, transient receptor potential vanilloid subfamily member 1 (TRPV1). This receptor is found on key sensory afferents, and so the use of capsaicin to selectively activate pain afferents has been studied in animal and human models for various indications. Capsaicin is unique among naturally occurring irritant compounds because the initial neuronal excitation evoked by it is followed by a long-lasting refractory period, during which the previously excited neurons are no longer responsive to a broad range of stimuli. This process known as defunctionalisation has been exploited for therapeutic use of capsaicin in various painful conditions. We reviewed different studies on mechanisms of action of capsaicin and its utility in different clinical conditions. A beneficial role of capsaicin has been reported in obesity, cardiovascular and gastrointestinal conditions, various cancers, neurogenic bladder, and dermatologic conditions. Various theories have been put forth to explain these effects. Interestingly many of these pharmacological actions are TRPV1 independent. This review is aimed at providing an overview of these mechanisms and to also present literature which contradicts the proposed beneficial effects of capsaicin. Most of the literature comes from animal studies and since many of these mechanisms are poorly understood, more investigation is required in human subjects.
Keywords: Capsaicin; Capsicum; Clinical utility; Mechanism; Pain; TRPV1 receptor.
© 2013 Elsevier B.V. All rights reserved.
Similar articles
-
The two faces of capsaicin.Cancer Res. 2011 Apr 15;71(8):2809-14. doi: 10.1158/0008-5472.CAN-10-3756. Epub 2011 Apr 12. Cancer Res. 2011. PMID: 21487045 Review.
-
Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.Int J Toxicol. 2007;26 Suppl 1:3-106. doi: 10.1080/10915810601163939. Int J Toxicol. 2007. PMID: 17365137 Review.
-
Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?Clin J Pain. 2008 Feb;24(2):142-54. doi: 10.1097/AJP.0b013e318158ed9e. Clin J Pain. 2008. PMID: 18209521 Review.
-
Recent developments in transient receptor potential vanilloid receptor 1 agonist-based therapies.Expert Opin Investig Drugs. 2004 Nov;13(11):1445-56. doi: 10.1517/13543784.13.11.1445. Expert Opin Investig Drugs. 2004. PMID: 15500392 Review.
-
Pharmacological activity of capsaicin: Mechanisms and controversies (Review).Mol Med Rep. 2024 Mar;29(3):38. doi: 10.3892/mmr.2024.13162. Epub 2024 Jan 19. Mol Med Rep. 2024. PMID: 38240083 Free PMC article. Review.
Cited by
-
Curcumin and capsaicin regulate apoptosis and alleviate intestinal inflammation induced by Clostridioides difficile in vitro.Ann Clin Microbiol Antimicrob. 2022 Sep 26;21(1):41. doi: 10.1186/s12941-022-00533-3. Ann Clin Microbiol Antimicrob. 2022. PMID: 36155114 Free PMC article.
-
Acute Intravesical Capsaicin for the Study of TRPV1 in the Lower Urinary Tract: Clinical Relevance and Potential for Innovation.Med Sci (Basel). 2022 Sep 10;10(3):50. doi: 10.3390/medsci10030050. Med Sci (Basel). 2022. PMID: 36135835 Free PMC article. Review.
-
Natural Herbal Non-Opioid Topical Pain Relievers-Comparison with Traditional Therapy.Pharmaceutics. 2022 Nov 29;14(12):2648. doi: 10.3390/pharmaceutics14122648. Pharmaceutics. 2022. PMID: 36559142 Free PMC article. Review.
-
Bioavailability of capsaicin and its implications for drug delivery.J Control Release. 2014 Dec 28;196:96-105. doi: 10.1016/j.jconrel.2014.09.027. Epub 2014 Oct 12. J Control Release. 2014. PMID: 25307998 Free PMC article. Review.
-
Effects of topical capsaicin combined with moderate exercise on insulin resistance, body weight and oxidative stress in hypoestrogenic obese rats.Int J Obes (Lond). 2017 May;41(5):750-758. doi: 10.1038/ijo.2017.33. Epub 2017 Feb 28. Int J Obes (Lond). 2017. PMID: 28163315
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources